Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Other Operating Expenses (2022 - 2024)

60 Degrees Pharmaceuticals (SXTP) has disclosed Other Operating Expenses for 3 consecutive years, with $19684.0 as the latest value for Q2 2024.

  • On a quarterly basis, Other Operating Expenses changed N/A to $19684.0 in Q2 2024 year-over-year; TTM through Mar 2025 was $19684.0, a 127.92% increase, with the full-year FY2024 number at -$163228.0, changed N/A from a year prior.
  • Other Operating Expenses was $19684.0 for Q2 2024 at 60 Degrees Pharmaceuticals, up from -$70490.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $231394.0 in Q2 2022 to a low of -$70490.0 in Q3 2023.
  • A 3-year average of $60196.0 and a median of $19684.0 in 2024 define the central range for Other Operating Expenses.